A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

“In Asia, people buy live birds at markets where they are plucked. The plucking has been shown to aerosolize virus from the ...

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Efforts have also ramped up to accelerate bird flu vaccine development. Last week, the federal Department of Health and Human Services announced it would provide about $590 million to Moderna to ...

Moderna led S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.

Since avian influenza, also known as bird flu ... and Human Services announced $590 million in support for Moderna to speed ...